If you have ever opened your portfolio after a bad market day and felt the loss with a sharper, longer, more visceral pain than the equivalent gain on a good day, you have lived inside the most foundational cognitive bias in behavioural finance: negativity bias. Roy Baumeister, Ellen Bratslavsky, Catrin Finkenauer and Kathleen Vohs published the canonical synthesis in 2001, in their landmark paper “Bad Is Stronger Than Good” (Review of General Psychology, Vol. 5, No. 4, 323–370). After reviewing decades of psychology research across emotion, cognition, learning, memory, marriage, parenting and decision-making, they concluded with one almost universal finding: bad events, bad feedback, bad outcomes and bad information have substantially greater psychological impact than equivalently strong good events. Their estimate, repeated across multiple sub-domains, was that the negative weight ratio sits somewhere between 2:1 and 5:1.
For an Indian retail investor in 2026, the practical translation is uncomfortable. A single ugly day on the Sensex is processed as roughly three good days. A single negative headline about a portfolio holding receives more attention than three rounds of clean quarterly numbers. A 15 percent drawdown registers as more emotionally consequential than a 60 percent multi-year gain. And the same machinery that kept our ancestors alive in a tiger-infested savanna now corrodes the long-term investor’s ability to hold quality businesses through ordinary market cycles.
This article is not investment advice. It teaches one bias, one set of counter-measures and one extended educational case study — Titan Biotech Ltd (BSE: 524717) — that illustrates what anti-negativity-bias corporate behaviour looks like in an Indian small-cap balance sheet. No company is being recommended for purchase, sale or holding.
1. What the Original 2001 Paper Actually Said
Baumeister and his co-authors were not the first to notice the asymmetry. Paul Rozin and Edward Royzman published an influential 2001 review the same year, “Negativity Bias, Negativity Dominance, and Contagion” (Personality and Social Psychology Review, 5, 296–320), which formalised four sub-phenomena: negative potency (bad has more weight than good of equal magnitude), steeper negative gradients (the closer we get to a bad event, the steeper the affect curve), negativity dominance (a single negative element in a mix dominates the whole) and negative differentiation (we discriminate finer grades of bad than of good).
The Baumeister team then took those four phenomena and showed how they manifest across virtually every psychology domain. In emotion, fear conditions in one trial; positive conditioning needs many repetitions. In memory, traumatic events crystallise; equivalent positive events fade. In impressions, one negative trait poisons the entire perception of a person; one positive trait rarely redeems a string of negatives. In marriages, John Gottman’s longitudinal work showed that stable couples have a positive-to-negative interaction ratio of roughly 5:1, while couples heading for divorce average around 0.8:1 — implying that one negative needs five positives just to maintain emotional parity.
The evolutionary explanation is intuitive. A failed signal that a tiger is in the grass costs an ancestor one false alarm. A missed signal costs them their life. Asymmetric error costs select for asymmetric sensitivity. Our brains were tuned by a million generations of selection pressure to weight negatives heavily because the alternative was to be removed from the gene pool.
2. The Underlying Psychology — Why Bad Sticks to the Investor’s Mind
Three neuro-cognitive mechanisms compound the bias inside a modern investor’s head.
(a) Faster amygdala recruitment. Functional MRI studies (notably Cunningham & Brosch, 2012, Current Directions in Psychological Science) show that the amygdala fires roughly 100 milliseconds faster in response to negatively valenced stimuli than to equally salient positive stimuli. By the time the prefrontal cortex consciously processes the news, the limbic system has already tagged it with an affect label. The investor “feels” the loss before they have parsed the numbers.
(b) Asymmetric attention. Tiffany Ito and John Cacioppo’s 1998 ERP work (Psychophysiology, 35, 387–397) showed that the brain’s “late positive potential” — a marker of attentional engagement — is larger for negative pictures than for positive ones of matched intensity. In market terms, an investor’s eye is pulled toward the red number on the screen even when the green number next to it is larger.
(c) Loss-aversion overlay. Daniel Kahneman and Amos Tversky’s prospect theory (1979) is essentially negativity bias in choice form — a loss feels roughly 2x to 2.5x as painful as an equivalent gain feels pleasurable. Negativity bias supplies the affective input; loss aversion encodes it into the value function that drives the actual portfolio decision.
The investor consequence is that a portfolio’s reported drawdown is not just a number — it is an emotional injury that the brain re-experiences every time the investor opens the broker app. Reported gains receive a fraction of the cognitive bandwidth.
3. The Indian Manifestation — Where Negativity Bias Shows Up on Dalal Street
India offers some of the cleanest natural experiments in negativity-bias behaviour, partly because the retail investor base has grown to 175 million unique demat accounts (NSE Cumulative Investor Distribution Data, March 2026) and partly because the F&O segment provides a near-real-time decision laboratory.
(i) SEBI’s January 2023 study on the F&O segment. The Securities and Exchange Board of India’s January 2023 study, “Analysis of Profit and Loss of Individual Traders in the Equity F&O Segment”, found that 89 percent of individual F&O traders incurred losses in FY22, with aggregate net losses of about ₹45,000 crore among the unprofitable cohort. SEBI’s follow-on September 2024 study extended the window to FY24 and reported a combined three-year loss of ₹1.81 lakh crore for retail traders. Behind that statistic sits negativity bias in two forms — first, the panic-flight from cash equities into options when the market falls; second, the “doubling down” reflex after a losing trade to repair the affective injury that the loss inflicted.
(ii) NSE’s 2024–25 Annual Report retention data. NSE’s market participation data show that of every 100 retail investors who opened a demat account during the 2020–21 bull cycle, only 41 traded in any month of 2024. The other 59 either went dormant or exited entirely. Behavioural-finance work by Prof. V. Ravi Anshuman of IIM Bangalore (“Investor Behaviour During Market Stress in India”, IIMB Management Review, 2022) attributes a meaningful share of this attrition to a peak-loss anchor formed during the March 2020 COVID drawdown and the late-2021 small-cap correction. Investors who experienced a deep mark-to-market loss in the first three months of their investing career carry that scar disproportionately, even after subsequent recovery.
(iii) AMFI SIP discontinuation data. The Association of Mutual Funds in India’s monthly data on SIP stoppage ratios (SIP closures / new SIP registrations) climbs visibly during market drawdowns. The ratio reached 88 percent in March 2024 versus a stable-period baseline of around 50 percent. Negativity bias supplies the emotional fuel: the SIP investor remembers the three months of red NAVs and forgets the seven years of compounding that preceded them.
(iv) The “WhatsApp forwarded headline” channel. Indian retail flows respond disproportionately to negative single-source items shared via messaging apps — promoter pledge concerns, regulatory show-cause notices, auditor resignations. The asymmetric sensitivity means that one such item can trigger a sell decision that a quarter of clean audited numbers cannot reverse.
Translating Rozin and Royzman’s “negativity dominance” finding into Indian portfolio terms: a single concerning headline contaminates the entire mental model of a holding, even if the underlying fundamental record is overwhelmingly positive.
4. The Counter-Measure Checklist — Reducing the Bias in Your Own Decision-Making
Negativity bias cannot be turned off; it is hardwired. It can, however, be structurally reduced through process design. The following six counter-measures are drawn from the cognitive-bias-correction literature and from the practices of experienced long-term investors.
(1) Pre-commit decisions in writing during calm periods. A written investment thesis with explicit pre-mortems and pre-defined exit triggers, recorded before the negative event occurs, dramatically reduces post-event panic. The pre-commitment converts a discretionary decision under emotional duress into a rule-based decision made by a calmer earlier self. Howard Marks’s memos repeatedly emphasise that “the worst time to make a long-term decision is in the middle of a short-term emotion.”
(2) Read positive and negative news in matched quantities. If you read three negative articles on a holding, read three positive analyst notes or three positive primary-source items (annual report sections, management commentaries, segment data). The deliberate symmetry counteracts the brain’s tendency to over-sample bad inputs.
(3) Maintain a “good news log”. Most investors maintain a mental record of losses and drawdowns. Almost none maintain a written record of clean quarters, returns of capital, dividend cheques and management actions that worked. A simple monthly log of positive verifiable corporate actions inside each holding shifts the affective balance over time.
(4) Convert single-event reactions into base-rate questions. When a negative headline arrives, the productive question is not “what does this mean?” but “what is the base rate of this category of event ending the long-term thesis?” Most negative items belong to a category that historically resolved without permanent capital impairment.
(5) Use a 30-day buffer before any sell decision triggered by a negative headline. Affect decays. A decision made 30 days after a headline is rarely the same decision made 30 minutes after.
(6) Audit your own portfolio interactions. Track how many minutes per week you spend looking at red versus green positions. If the time allocation is asymmetric, you are inhaling the bias whether you realise it or not.
5. How the Greats Addressed Negativity Bias
Benjamin Graham (The Intelligent Investor, 1949). Graham’s “Mr Market” allegory in Chapter 8 is essentially an antidote to negativity bias dressed in literary clothing. The investor is told to treat the market’s daily price quotes — most of which are noise — as moods of a manic-depressive business partner, not as signals. The negativity bias the market feels is not your bias to absorb.
Warren Buffett. Buffett’s celebrated reluctance to monitor stock prices, his preference for reading 10-Ks over watching CNBC, and his observation that “the stock market is a device for transferring money from the impatient to the patient” all describe behavioural disciplines that disarm negativity bias at the source — limiting the negative-stimulus inflow.
Charlie Munger. Munger’s “invert, always invert” mental model is directly relevant. Instead of asking “how do I make money?” he asks “how do I avoid losing it?” — which sounds like it amplifies negativity bias, but in fact it converts unbounded vague negative anxiety into a finite, checklistable list of failure modes that can be inspected and managed.
Seth Klarman (Margin of Safety, 1991). Klarman builds a structural margin of safety into every position so that ordinary negative events do not trigger emotional re-evaluation. The cognitive buffer is paid for in entry-price discipline.
Howard Marks. Marks’s “second-level thinking” forces the investor to ask not “is this news bad?” but “how much of this bad news is already in the price?” — which converts the bias-driven flinch into an analytical question with a tractable answer.
6. Illustrative Case — How Titan Biotech Ltd (BSE: 524717) Exhibits Anti-Negativity-Bias Symmetry in Corporate Disclosure
This section is an educational case study of management process and disclosure architecture. It is not a buy, sell, hold, accumulate or reduce call on the security. No price target, intrinsic-value estimate or valuation verdict is being offered. Investors are requested to consult their SEBI-registered investment advisor and conduct independent due diligence.
Negativity bias works in two directions in capital markets. On the investor side, it causes overreaction to negative news. On the corporate side, it tempts managements to hide or muffle negatives so that investor reactions stay sedated. The disciplined corporate behaviour is the opposite — to disclose negatives openly, with the same prominence as positives, so that long-term investors can calibrate the full risk profile without the brain’s negativity dominance amplifying hidden surprises.
Titan Biotech Ltd’s FY25 audited annual report and consolidated financials offer a useful illustration of what anti-negativity-bias symmetric corporate disclosure looks like in an Indian small-cap. The numbers below are drawn from the company’s audited FY25 annual report, consolidated financial statements and publicly disclosed quarterly results.
| Marker | Audited FY25 Number | Behavioural Interpretation |
|---|---|---|
| Contingent liabilities disclosed | ₹7.78 crore (5.08% of net worth), down 39.7% YoY from ₹12.90 crore in FY24 | Symmetric disclosure of a “negative” line item. Most investors have to dig to find this; Titan reports it prominently. Lowers the unknown-negative space, shrinking the surface area on which negativity bias can amplify. |
| Borrowings on balance sheet | ₹3 crore (FY25) versus ₹16 crore (FY21) — an 81% reduction | A multi-year deleveraging trajectory is reported each year, including in years where market sentiment was neutral. The negative-news category “rising leverage” is structurally absent. Investors do not have to fight negativity bias on a debt headline that does not exist. |
| CFO / Operating profit conversion | 103% (FY25), 85% (FY24), 97% (FY23) | Cash conversion is reported with the same prominence as accounting profit. Symmetric exposure of the cash quality line — where most negative governance surprises emerge in Indian small-caps — protects investors from a hidden-negative shock. |
| Board independence and engagement | 11 directors, 4 independent (36.4%), 2 women directors (18.2%), independent chair, 14 board meetings in FY25 | Quantified disclosure of board composition and meeting frequency. A poorly-engaged board is the most under-reported negative in Indian small-cap governance. Disclosing the engagement cadence in concrete numbers removes the ambiguity that negativity bias normally feeds on. |
| Director remuneration | ~₹4.56 crore total director compensation in FY25 | Compensation transparency. Hidden management compensation is a classic latent-negative in Indian small-caps. Open disclosure converts it into a quantitative number investors can verify against peer norms. |
| Gross fixed assets growth | ₹57 crore (FY25) vs ₹11 crore (FY15) — 5.2x over 10 years | Both the capex and the depreciation that follows are disclosed. Depreciation ratio of ~7.0% of gross block (vs peer ~4–5%) is published — Titan reports a marker that other peers would prefer to obscure. Negative-on-near-term-earnings, positive-on-asset-honesty. |
| CWIP visibility | ₹4 crore (Sept 2025); peak was ₹13 crore in FY23 | Capital under construction is shown both at peak and at draw-down. The “stuck capex” risk, normally invisible in Indian small-cap balance sheets, is fully disclosed. Eliminates a category of unknown-negative. |
| Quarterly revenue trajectory FY26 | Q1: ₹46.50 Cr; Q2: ₹54 Cr; Q3: ₹56 Cr — three consecutive QoQ increases | Quarterly cadence allows investors to track operating trajectory in real time rather than waiting for a single annual headline that the negativity-biased brain will over-weight. Continuous data reduces affective shock. |
| Segment mix disclosure | Domestic ₹10,254.80 lakh + Overseas ₹5,390.28 lakh (~34.5% export share, 60+ countries) | Geographic risk is disclosed with concrete numbers. A “concentration risk” headline cannot be manufactured against a 34.5%-diversified export profile that is reported each year. |
The behavioural reading is consistent across all nine markers. Titan Biotech’s FY25 audited disclosure architecture does not attempt to hide or muffle negatives. Contingent liabilities, depreciation drag, CWIP balances, board engagement counts and director remuneration are all published in concrete numbers. The corporate behaviour is symmetric — the positives (15% 10-year sales CAGR, 29% 10-year profit CAGR, 16.9% ROCE, ~15% ROE, ₹22 crore FY25 consolidated net profit on ~19% TTM revenue growth, market cap ₹1,779 crore at ₹430 as of 15 April 2026) are reported with the same prominence as the negatives.
For a behavioural-finance long-term investor, the practical value of this kind of symmetric disclosure is that it shrinks the “unknown negative” surface area on which negativity bias normally operates. When the next concerning headline arrives — and headlines always arrive — the investor can place it inside a base of audited disclosed numbers rather than reacting to it as a sudden revelation. None of this constitutes a valuation call or a recommendation. It is a process observation about how a particular Indian small-cap chooses to communicate with its shareholders.
7. Key Takeaways for the Indian Long-Term Investor
Negativity bias is not a flaw the investor can argue with; it is a feature of human neural architecture refined by a million generations of selection. What the investor can do is reshape the decision environment so that the bias has less raw material to amplify.
The actionable summary, drawn from the academic literature and the disclosure example above:
- Bad is roughly three times stronger than good in the human mind (Baumeister et al., 2001). Calibrate your reaction by the same multiple — divide your initial emotional intensity by three before acting.
- Pre-commit decisions in calm periods. A written exit rule formulated in a calm month is worth a hundred discretionary decisions made in a panicked one.
- Demand symmetric disclosure from companies you own. The Titan Biotech FY25 audited annual report disclosed contingent liabilities of ₹7.78 crore (down 39.7% YoY) with the same prominence as its 103% FY25 CFO/operating profit conversion ratio — a useful illustration of what symmetric, anti-negativity-bias corporate disclosure looks like in an Indian small-cap. Holdings whose managements obscure negatives leave the investor’s negativity bias fully exposed to surprise.
- Maintain a written good-news log to balance the brain’s automatic bad-news log.
- Treat single negative headlines as questions, not answers. Convert “is this bad?” into “what is the base rate of this category of event ending the long-term thesis?”
- Use a 30-day affect-decay buffer before any sell decision triggered by a negative headline. Most affect decays inside 30 days; structural problems do not.
The market does not reward investors for feeling everything equally; it rewards investors for thinking clearly through asymmetric emotional input. The first step in that discipline is naming the bias.
Disclaimer: This article is for educational and informational purposes only. It is not investment advice, and not a buy, sell, or hold recommendation on any stock mentioned, including Titan Biotech Limited. Equity markets carry risk; please do your own research or consult a qualified professional before making investment decisions.
